5[3]Martha Mitch Funnell. Robert M. Anderson. The problem with compliance in diabetes. JAMA ,2000,284 ( 13 ): 1709.
6[6]Tebbi CK. Treatment compliance in childhood and adolescence. Cancer, 1993,71:3441.
7[7]Vaur L, Vaisse B, Genes N, et al. Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large - scale trial. Am J Hypertens, 1999,12 (4 Pt 1 ): 374-380.
8[8]Andrejak M,Genes N,Vaur L,et al. Electronic pill boxes in the evaluation of antihypertensive treatment compliance:Comparison of once daily versus twice daily regimen. Am J Hypertens,2000,13 (2) :184-190.
9[9]Van Berge Henegouwen MT. Van Driel HF. Kasteleijn Nolst Trenite DG. A patient diary as a tool to improve medicine compliance. PharmWorldSci. 1999, 21 (1): 21 -24.
10[10]Spooren D,Van Heeringen C,Jannes C. Strategies to increase compliance with outpatient aftercare among patients referred to a psychiatric emergency department: a multicentre controlled intervention study.Psychol Med, 1998,28 (4) :949 - 956.
6Hedner T, Narkiewicz E, Kjeldsen SE. Cost-effectiveness of blood pressure measurement and hypertension follow-up [ J ]. Blood Pres- sure ,2006,15 ( 1 ) :4 - 5.
7Van Leer EM, Seidell JC, Kromhout D. Levels and trends in blood pressure and prevalence and treatment of hypertension in the Neth- erlands, 1987 - 1991 [J]. Am J Prey Med, 1994, 10 (4): 194 - 199.
9Ezzati M, Lopez AD, Vander Hoorn S, et al. Selected major risk factors and global and regional burden of dis- ease [ J ]. Lancet, 2002,360 (9343) : 1347 - 1360.
